IL-1β-induced OA-CH were treated with different concentrations of EVs and the data revealed that EVs with a concentration of ≥ 5 μg/ml reversed increased caspase 3/7 activity of OA-CH induced by IL-1β (Fig. 2i). The gene discussed is CASP3; the disease is cyclic hematopoiesis.